Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

150 ARTÍCULOS , VIENDO DEL 1 AL 15

Integrated Biomarkers for Depression in Alzheimer's Disease: A Critical Review

Wenzler S, Knochel C, Balaban C, Kraft D, Kopf J, Alves GS, Prvulovic D, Carvalho AF, Oertel-Knochel V.

Curr Alzheimer Res. 2017;14(4):441-452. doi: 10.2174/1567205013666160603011256.

Amyloid Imaging: Poised for Integration into Medical Practice

Anand K, Sabbagh M.

Neurotherapeutics. 2017 Jan;14(1):54-61. doi: 10.1007/s13311-016-0474-y.

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team

Arnerić SP, Batrla-Utermann R, Beckett L, Bittner T, Blennow K, Carter L, Dean R, Engelborghs S, Genius J, Gordon MF, Hitchcock J, Kaplow J, Luthman J, Meibach R, Raunig D, Romero K, Samtani MN, Savage M, Shaw L, Stephenson D, Umek RM, Vanderstichele H, Willis B, Yule S.

J Alzheimers Dis. 2017;55(1):19-35. doi: 10.3233/JAD-160573.

Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors

Rivero-Santana A, Ferreira D, Perestelo-Pérez L, Westman E, Wahlund LO, Sarría A, Serrano-Aguilar P.

J Alzheimers Dis. 2017;55(2):625-644. doi: 10.3233/JAD-160366.

Biomarkers for the Early Detection and Progression of Alzheimer's Disease

Counts SE, Ikonomovic MD, Mercado N, Vega IE, Mufson EJ.

Neurotherapeutics. 2017 Jan;14(1):35-53. doi: 10.1007/s13311-016-0481-z.

Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress

Keshavan A, Heslegrave A, Zetterberg H, Schott JM.

Mol Diagn Ther. 2017 Feb;21(1):13-22. doi: 10.1007/s40291-016-0241-0.

Comparison of Extracellular and Intracellular Blood Compartments Highlights Redox Alterations in Alzheimer's and Mild Cognitive Impairment Patients

Arce-Varas N, Abate G, Prandelli C, Martínez C, Cuetos F, Menéndez M, Marziano M, Cabrera-García D, Fernández-Sánchez MT, Novelli A, Memo M, Uberti D.

Curr Alzheimer Res. 2017;14(1):112-122. doi: 10.2174/1567205013666161010125413.

Tau Imaging in Alzheimer's Disease Diagnosis and Clinical Trials

Brosch JR, Farlow MR, Risacher SL, Apostolova LG.

Neurotherapeutics. 2017 Jan;14(1):62-68. doi: 10.1007/s13311-016-0490-y.

Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?

Squitti R, Mendez AJ, Simonelli I, Ricordi C.

J Alzheimers Dis. 2017;56(3):1055-1064. doi: 10.3233/JAD-161033.

The application of lipidomics to biomarker research and pathomechanisms in Alzheimer's disease

Wong MW, Braidy N, Poljak A, Sachdev PS.

Curr Opin Psychiatry. 2017 Mar;30(2):136-144. doi: 10.1097/YCO.0000000000000303.

Cognitive decline and dementia in Down syndrome

Hithersay R, Hamburg S, Knight B, Strydom A.

Curr Opin Psychiatry. 2017 Mar;30(2):102-107. doi: 10.1097/YCO.0000000000000307.

Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes

van Waalwijk van Doorn LJ, Gispert JD, Kuiperij HB, Claassen JA, Arighi A, Baldeiras I, Blennow K, Bozzali M, Castelo-Branco M, Cavedo E, Emek-Savaş DD, Eren E, Eusebi P, Farotti L, Fenoglio C, Ormaechea JF, Freund-Levi Y, Frisoni GB, Galimberti D, Genc S, Greco V, Hampel H, Herukka SK, Liu Y, Lladó A, Lleó A, Nobili FM, Oguz KK, Parnetti L, Pereira J, Picco A, Pikkarainen M, de Oliveira CR, Saka E, Salvadori N, Sanchez-Valle R, Santana I, Scarpini E, Scheltens P, Soininen H, Tarducci R, Teunissen C, Tsolaki M, Urbani A, Vilaplana E, Visser PJ, Wallin AK, Yener G, Molinuevo JL, Meulenbroek O, Verbeek MM.

J Alzheimers Dis. 2017;56(2):543-555. doi: 10.3233/JAD-160668.

A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor

Han P, Serrano G, Beach TG, Caselli RJ, Yin J, Zhuang N, Shi J.

J Neuropathol Exp Neurol. 2017 Jan 1;76(1):44-51. doi: 10.1093/jnen/nlw105.

Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease

Tomita T.

Adv Biol Regul. 2017 May;64:33-38. doi: 10.1016/j.jbior.2017.01.001. Epub 2017 Jan 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias